Results 181 to 190 of about 47,265,557 (210)

Drug Targets in Human T-Lymphotropic Virus Type 1 (HTLV-1) Infection

Infectious Disorders - Drug Targets, 2009
Human T-lymphotropic virus type 1 (HTLV-1), the first known human retrovirus, induces various human diseases with a long latency period. The mechanism by which the virus causes diseases is still unknown. Studies indicate that viral replication is important at least for the development of HTLV-1 associated myelopathy, and therefore treatments based on ...
Péter, Boross, Péter, Bagossi, Irene T, Weber, József, Tözsér   +3 more
openaire   +2 more sources

Concomitant Infections with Human Immunodeficiency Virus Type 1 and Human T-Lymphotropic Virus Types 1 and 2

2014
Two distinct families of human retroviruses, the human immunodeficiency viruses (HIVs) and human T-lymphotropic viruses (HTLVs), cause significant infections worldwide. The viruses have common modes of transmission, both vertically and horizontally, and share an in vivo tropism for cells of the immune system, and in particular, T lymphocytes.
Abelardo Araujo, Noreen Sheehy, Hidehiro Takahashi, William W. Hall   +3 more
openaire   +1 more source

Human T-Lymphotropic Virus Type 1 (HTLV-1): Persistence and Immune Control

International Journal of Hematology, 2003
The human retrovirus human T-lymphotropic virus type 1 (HTLV-1) is associated with two distinct types of disease: the malignancy known as adult T-cell leukemia and a range of chronic inflammatory conditions including the central nervous system disease HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
openaire   +2 more sources

Cervical cancer prevention and control in women living with human immunodeficiency virus

Ca-A Cancer Journal for Clinicians, 2021
Vikrant V Sahasrabuddhe, Philip E Castle, Mark H Einstein   +2 more
exaly  

Human T lymphotropic virus type 1 (HTLV-1)

2020
Shila Azodi, Steven Jacobson
openaire   +1 more source

Human T-Lymphotropic Virus Type-1 Infection

2019
W. Heneine, W. M. Switzer
openaire   +1 more source

Modelling the diversity and persistence of the human T-lymphotropic virus type-1

2014
Human T-lymphotropic virus type-1 (HTLV-1) infects approximately 10-20 million people worldwide. The virus persists within hosts via de novo infection and infected cell proliferation, creating a population structure of multiple clones (infected cell populations with identical genomic proviral integration sites).
openaire   +2 more sources

Human T-Lymphotropic Virus Type 1 Infection

2020
openaire   +1 more source

Human T-Lymphotropic Virus Type 1 and Its Ocular Manifestations

International Ophthalmology Clinics, 1995
openaire   +2 more sources

Human T-Lymphotropic Virus-1/2 Infection in Central Brazil Prisons: A Multicenter Study

Frontiers in Microbiology, 2022
Marco Antonio Moreira Puga, Julio Croda, Larissa Bandeira   +2 more
exaly